Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C03DA04	EPLERENONE ARROW	G	Eplerenone - 25mg	25mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE BIOGARAN	G	Eplerenone - 25mg	25mg	Tablet, coated	1,849,127 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE BIOGARAN	G	Eplerenone - 50mg	50mg	Tablet, coated	1,849,127 L.L
L02BG06	EXEMESTANE BGR	G	Exemestane - 25mg	25mg	Tablet, coated	4,479,027 L.L
J05AF10	ENTECAVIR ARROW	G	Entecavir - 1mg	1mg	Tablet, coated	L.L
J05AF10	ENTECAVIR ARROW	G	Entecavir - 0.5mg	0.5mg	Tablet, coated	L.L
R06AX22	EBASTINE ARROW	G	Ebastine - 10mg	10mg	Tablet, coated	524,099 L.L
J05AF10	ENTECAVIR ARROW	G	Entecavir - 1mg	1mg	Tablet, coated	18,701,506 L.L
J05AF10	ENTECAVIR BIOGARAN	G	Entecavir - 1mg	1mg	Tablet, coated	19,080,319 L.L
J05AF10	ENTECAVIR ARROW	G	Entecavir - 0.5mg	0.5mg	Tablet, coated	18,701,506 L.L
J05AF10	ENTECAVIR BIOGARAN	G	Entecavir - 0.5mg	0.5mg	Tablet, coated	19,080,319 L.L
G03XC01	EVA TABLET	G	Raloxifene HCl - 60mg	60mg	Tablet	1,354,081 L.L
C09BB06	ENEAS	G	Enalapril maleate - 10mg, Nitrendipine - 20mg		Tablet	2,009,045 L.L
C03AA03	ESIDREX	B	Hydrochlorothiazide - 25mg	25mg	Tablet	380,115 L.L
A07BA51	EUCARBON	B	Rhubarbe - 25mg, Sulfur - 50mg, Senna - 105mg, Vegetal charcoal - 180mg		Tablet	795,555 L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 2.5mg	2.5mg	Tablet	L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 5mg	5mg	Tablet	L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 10mg	10mg	Tablet	L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 5mg	5mg	Tablet	73,160,279 L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 5mg	5mg	Tablet	89,386,347 L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 10mg	10mg	Tablet	91,752,764 L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 10mg	10mg	Tablet	124,701,632 L.L
L01EG02	EVEROLIMUS ARROW	G	Everolimus - 2.5mg	2.5mg	Tablet	57,802,039 L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 2.5mg	2.5mg	Tablet	52,290,378 L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 5mg	5mg	Tablet	L.L
L01EG02	EVEROLIMUS BIOGARAN	G	Everolimus - 10mg	10mg	Tablet	L.L
C09CA09	EDARBI	B	Azilsartan medoxomil - 40mg	40mg	Tablet	1,846,440 L.L

...